---
title: "APRE.US (APRE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/APRE.US/news.md"
symbol: "APRE.US"
name: "APRE.US"
parent: "https://longbridge.com/en/quote/APRE.US.md"
datetime: "2026-05-20T04:31:05.505Z"
locales:
  - [en](https://longbridge.com/en/quote/APRE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/APRE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/APRE.US/news.md)
---

# APRE.US (APRE.US) — Related News

### [Analyst Reiterates Buy on Aprea as APR-1051 Data and Cash Runway Support Unchanged $5 Price Target](https://longbridge.com/en/news/286462934.md)
*2026-05-14T20:15:16.000Z*
> Maxim Group analyst Jason McCarthy has reiterated a Buy rating on Aprea (APRE) stock, maintaining a $5 price target. His

### [Key facts: APRE APR‑1051, ATRN‑119 progress; Q1 loss $0.22](https://longbridge.com/en/news/286379412.md)
*2026-05-14T07:54:25.000Z*
> APRE reported a Q1 adjusted loss of $0.22 per share with a net loss of $3.29 million and no revenue. The company’s APR-1

### [Aprea Therapeutics, Inc. 1Q 2026: Revenue $0 EPS $(0.22) — 10-Q Summary](https://longbridge.com/en/news/286245980.md)
*2026-05-13T10:51:00.000Z*
> Aprea Therapeutics, Inc. reported Q1 2026 results with $0 revenue and a net loss of $(3.29M), an improvement from $(3.93

### [Aprea Therapeutics | 8-K: FY2026 Q1 Revenue Meets Estimate at USD 0](https://longbridge.com/en/news/286243356.md)
*2026-05-13T10:37:56.000Z*
### [Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update](https://longbridge.com/en/news/286245340.md)
*2026-05-13T10:31:43.000Z*
> On May 13, 2026, in Doylestown, Pennsylvania, Aprea Therapeutics, Inc. (Nasdaq: APRE), a company specializing in precisi

### [This Aprea Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday](https://longbridge.com/en/news/285593559.md)
*2026-05-07T17:27:14.000Z*
> Top Wall Street analysts have initiated coverage on Aprea Therapeutics (APRE), Surf Air Mobility (SRFM), and CNH Industr

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/en/news/285070365.md)
*2026-05-04T12:06:22.000Z*
> In Monday's pre-market session, CNS Pharmaceuticals (CNSP) saw a significant gain of 263.5%, reaching $8.4, while Rallyb